Table 3: Antimicrobial susceptibilities profiles of A.baumanii isolates and carbapenem resistant A.baumanii from ICU patients at Khartoum state selected hospitals.
|
Antibiotic disc µg/ml |
A.baumanii (n = 39) |
CP- A.baumanii (n = 22) |
|
|
||
|
Resistance N (%) |
Sensitive N (%) |
Resistance N (%) |
Sensitive N (%) |
P value |
X2 |
|
|
Ciprofloxacin |
39 (100%) |
0 (0.0%) |
22 (100%) |
0 (0.0%) |
0.000* |
1 |
|
Cefixime |
39 (100%) |
0 (0.0%) |
22 (100%) |
0 (0.0%) |
0.000* |
1 |
|
Ceftazidime |
39 (100%) |
0 (0.0%) |
22 (100%) |
0 (0.0%) |
0.000* |
1 |
|
Gentamycin |
39 (100%) |
0 (0.0%) |
22 (100%) |
0 (0.0%) |
0.000* |
1 |
|
Ceftriaxone |
39 (100%) |
0 (0.0%) |
22 (100%) |
0 (0.0%) |
0.000* |
1 |
|
AMC* |
39 (100%) |
0 (0.0%) |
22 (100%) |
0 (0.0%) |
0.000* |
1 |
|
Cefuroxime |
39 (100%) |
0 (0.0%) |
22 (100%) |
0 (0.0%) |
0.000* |
1 |
|
Colistin |
23 (59.0%) |
16 (41.0%) |
14 (63.6%) |
8 (36.4%) |
0.171 |
1.528 |
|
Meropenem |
38 (97.4%) |
1 (2.6%) |
22 (100%) |
0 (0.0%) |
0.000* |
1 |
*Antibiotic disc concentrations in μg/ml, AMC; Amoxacillin/Clavulanic Acid, *Sig. P value < 0.05, CP- A.baumanii; Carbapenemase producing- A.baumanii.